compound glp 1 news Diabetes advocacy group discourages use of compounded GLP-1 drugs Fifth Circuit probes FDA ban

What's the TGA doing about this

Never sacrifice quality for savings by using unverified research chemicals

Several pieces of evidence demonstrate that GLP-1R agonists target the hindbrain and multiple hypothalamic nuclei ( e

Another RCT examined the effect of B1 (300 mg/d), B6 (80 mg/d), B9 (2mg/d), B12 (500 g/d) supplements and B-complex for 12 weeks on patients with migraine, compared with the placebo

How much weight loss is needed before arthritis symptoms improve

In this Review, we discuss the current knowledge of NAD + metabolism, including limitations of, assumptions about and unappreciated factors that might influence the success or contribute to risks of NAD + supplementation